Revenue: The sum of all revenue fields included for a company's operating activities.
Yew Bio-Pharm Group Inc. (YEWB) had Revenue of $27.31M for the most recently reported fiscal year, ending 2020-12-31.
| Income Statement Financials | |
|
Revenue |
$27.31M |
$1.46M |
|
$23.78M |
|
$3.53M |
|
$24.74M |
|
$2.57M |
|
$-1.07M |
|
$1.49M |
|
$1.49M |
|
$1.46M |
|
$1.46M |
|
$1.46M |
|
$1.46M |
|
$2.57M |
|
$5.39M |
|
51.70M |
|
51.70M |
|
$0.03 |
|
$0.03 |
|
| Balance Sheet Financials | |
$9.99M |
|
$0.49M |
|
$48.46M |
|
$58.45M |
|
$10.53M |
|
-- |
|
$2.44M |
|
$12.96M |
|
$45.48M |
|
$3.50M |
|
$45.48M |
|
51.70M |
|
| Cash Flow Statement Financials | |
$17.34M |
|
$-17.36M |
|
$-0.01M |
|
$0.74M |
|
$0.56M |
|
$-0.18M |
|
$0.00M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.95 |
|
-- |
|
-- |
|
-- |
|
0.21 |
|
12.92% |
|
9.41% |
|
9.41% |
|
19.72% |
|
5.47% |
|
5.36% |
|
$12.69M |
|
-- |
|
-- |
|
-- |
|
0.47 |
|
1627.92 |
|
2.93 |
|
124.57 |
|
3.22% |
|
41.83% |
|
2.51% |
|
3.22% |
|
$0.88 |
|
$0.25 |
|
$0.34 |
|